Thromboembolic Events
Inform patients and/or caregivers that HYMPAVZI increases coagulation potential. Discuss the appropriate dosing of concomitant agents such as FVIII or FIX with the patient prior to starting on HYMPAVZI prophylaxis [see Warnings and Precautions (5.1)]. Advise the patient to seek immediate medical attention if any signs or symptoms of thromboembolism occur.
Hypersensitivity
Inform patients and/or caregivers that hypersensitivity reactions such as rash and pruritus are possible. Advise patients to discontinue HYMPAVZI and seek immediate emergency treatment if a severe hypersensitivity reaction occurs [see Warnings and Precautions (5.2)].
Pregnancy
Advise female patients of reproductive potential to use effective contraception during treatment with HYMPAVZI and for 2 months after the last dose. Advise patients to report known pregnancies [see Warnings and Precautions (5.3) and Use in Specific Populations (8.1, 8.3)].
This product’s labeling may have been updated. For the most recent prescribing information, please visit www.pfizer.com.
For medical information about HYMPAVZI, please visit www.pfizermedinfo.com or call 1-800-438-1985.
US License No. 2001
Distributed by
Pfizer Labs
Division of Pfizer Inc.
New York, NY 10001
LAB-1556-1.0
This Patient Information has been approved by the U.S. Food and Drug Administration. Issued: 10/2024 | ||
PATIENT INFORMATION HYMPAVZI (him-PAV-zee) (marstacimab-hncq) injection, for subcutaneous use | ||
Important information: Before you start using HYMPAVZI, it is very important to talk to your healthcare provider about using factor VIII and factor IX products (products that help blood clot but work in a different way than HYMPAVZI). You may need to use factor VIII or factor IX medicines to treat episodes of breakthrough bleeding during treatment with HYMPAVZI. Carefully follow your healthcare provider’s instructions regarding when to use factor VIII or factor IX medicines and the prescribed dose during your treatment with HYMPAVZI. | ||
What is HYMPAVZI? HYMPAVZI is a prescription medicine used to prevent or reduce the frequency of bleeding episodes in adults and children 12 years of age and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors. It is not known if HYMPAVZI is safe and effective in children younger than 12 years old. | ||
Before using HYMPAVZI, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription medicines, over‑the‑counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine. | ||
How should I use HYMPAVZI? See the detailed “Instructions for Use” that comes with your HYMPAVZI for information on how to inject a dose of HYMPAVZI, and how to properly throw away (dispose of) used HYMPAVZI prefilled syringe or HYMPAVZI prefilled pen.
| ||
What are the possible side effects of HYMPAVZI? HYMPAVZI may cause serious side effects, including:
| ||
|
| |
| ||
|
| |
The most common side effects of HYMPAVZI are injection site reactions, including: | ||
|
| |
These are not all of the possible side effects of HYMPAVZI. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. | ||
How should I store HYMPAVZI?
Keep HYMPAVZI and all medicines out of the reach of children. | ||
General information about the safe and effective use of HYMPAVZI. Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use HYMPAVZI for a condition for which it was not prescribed. Do not give HYMPAVZI to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about HYMPAVZI that is written for health professionals. | ||
What are the ingredients in HYMPAVZI? Active ingredient: marstacimab‑hncq Inactive ingredients: edetate disodium, histidine, L-histidine monohydrochloride, polysorbate 80, sucrose, and water for injection | ||
This product's labeling may have been updated. For the most recent prescribing information, please visit www.pfizer.com.
|
INSTRUCTIONS FOR USE
HYMPAVZI™ (him-PAV-zee)
(marstacimab-hncq)
injection, for subcutaneous use
single-dose prefilled syringe
This Instructions for Use contains information on how to inject HYMPAVZI.
Read this Instructions for Use carefully before using HYMPAVZI Prefilled Syringe and each time you get a refill prescription as there may be new information.
Your healthcare provider should show you or your caregiver how to prepare and inject a dose of HYMPAVZI the right way before you use it for the first time. Do not inject yourself or someone else until you have been shown how to inject HYMPAVZI.
Important Information You Need to Know Before Injecting HYMPAVZI
Storing HYMPAVZI
Supplies Needed For HYMPAVZI Injection
Gather the following supplies on a clean flat surface:
Included in the carton:
Not included in the carton:
HYMPAVZI Prefilled Syringe
Always hold HYMPAVZI Prefilled Syringe by the barrel to prevent damage.
Preparing to Inject HYMPAVZI
Step 1 – Getting Ready
Note: For a more comfortable injection, allow the Syringe to warm up to room temperature in the carton away from direct sunlight for about 15 to 30 minutes.
Do not use any other methods to warm up the Syringe, such as warming the Syringe in a microwave or hot water.
Step 2 – Check Expiration Date
Step 3 – Check Medicine
Note: It is normal to see air bubbles in the Syringe.
If you have any questions about the medicine, contact your healthcare provider.
Step 4 – Choose and Clean Your Injection Site
Step 5 – Remove Cover
Note: It is normal to see a few drops of medicine at the needle tip.
Caution: Handle the Syringe with care to avoid an accidental needle injury.
Injecting HYMPAVZI
Step 6 – Insert Needle
Keep your skin pinched throughout the injection.
Caution: If you change your mind where to inject after inserting the needle into your skin, you will need to throw away (dispose of) the Syringe and get a new HYMPAVZI Prefilled Syringe.
Step 7 – Inject Medicine
Note: Count slowly to 5 after the plunger rod has been fully pushed down before removing the needle from your skin.
Step 8 – Remove Needle
Note: If you see a small drop of medicine on your skin, wait a little longer before removing the needle when you give your next injection.
Step 9 – Check Syringe
If the gray plunger stopper is not in the position shown, this means you have not received a full dose. Call your healthcare provider for help.
Never re-insert the needle.
Do not inject another dose.
Step 10 – After Care
Note: If bleeding does not stop, contact your healthcare provider.
Note: If your prescribed dose requires 2 injections of HYMPAVZI, repeat steps 1-10. Change (rotate) the injection site each time you give yourself an injection of HYMPAVZI. You may use the same area of your body but be sure to choose a different injection site in that area.
Never re-cap the needle.
Note: If you do not have an FDA-cleared sharps disposal container, please see the “Safe Syringe Disposal” information section.
US License No. 2001
Distributed by
Pfizer Labs
Division of Pfizer Inc.
New York, NY 10001
LAB-1576-1.0
For more information, go to www.pfizer.com or call 1-800-438-1985.
This Instructions for Use has been approved by the U.S. Food and Drug Administration. Issued: 10/2024
INSTRUCTIONS FOR USE
HYMPAVZI™ (him-PAV-zee)
(marstacimab-hncq)
injection, for subcutaneous use
single-dose prefilled pen
This Instructions for Use contains information on how to inject HYMPAVZI.
Read this Instructions for Use carefully before using HYMPAVZI Prefilled Pen and each time you get a refill prescription as there may be new information.
Your healthcare provider should show you or your caregiver how to prepare and inject a dose of HYMPAVZI the right way before you use it for the first time. Do not inject yourself or someone else until you have been shown how to inject HYMPAVZI.
Important Information You Need to Know Before Injecting HYMPAVZI
Storing HYMPAVZI
Supplies Needed For HYMPAVZI Injection
Gather the following supplies on a clean flat surface:
Included in the carton:
Not included in the carton:
HYMPAVZI Prefilled Pen
Preparing to Inject HYMPAVZI
Step 1 – Getting Ready
Note: For a more comfortable injection, allow the Pen to warm up to room temperature in the carton away from direct sunlight for about 15 to 30 minutes.
Do not use any other methods to warm up the Pen, such as warming the Pen in a microwave or hot water.
Step 2 – Check Expiration Date
Step 3 – Check Medicine
Note: It is normal to see air bubbles in the window.
If you have any questions about the medicine, contact your healthcare provider.
Step 4 – Choose and Clean Your Injection Site
Step 5 – Twist Off Cap
Note:
Caution: Handle the Pen with care as it contains a needle.
Do not put or press your hand over the needle guard. Doing so may cause a needle injury.
Injecting HYMPAVZI
Step 6 – Inject Medicine
Do not remove the Pen from your skin until you have counted slowly to 5 after you hear the 2nd click and until the yellow marker completely fills the window (see “Step 7 – Remove Pen”).
Note: The needle goes into your skin as you push the Pen down. Your healthcare provider may suggest gently pinching your skin while you inject.
Note: If you do not hear a click when pushing the Pen against your skin, try pushing down harder. If you still cannot start the injection, get a new HYMPAVZI Prefilled Pen.
Caution: If you change your mind where to inject after inserting the needle into your skin, you will need to throw away (dispose of) the Pen and get a new HYMPAVZI Prefilled Pen.
Note: After you remove the Pen from your skin, the needle guard will automatically cover the needle and lock in place.
The Pen cannot be reused.
Step 8 – Check Window
If the yellow bar is not in the position shown, this means you have not received a full dose. Call your healthcare provider for help.
Do not inject another dose.
Step 9 – After Care
Note: If bleeding does not stop, contact your healthcare provider.
Note: If your prescribed dose requires 2 injections of HYMPAVZI, repeat steps 1-9. Change (rotate) the injection site each time you give yourself an injection of HYMPAVZI. You may use the same area of your body but be sure to choose a different injection site in that area.
Note: If you do not have an FDA-cleared sharps disposal container, please see the “Safe Pen Disposal” information section.
US License No. 2001
Distributed by
Pfizer Labs
Division of Pfizer Inc.
New York, NY 10001
LAB-1577-1.0
For more information, go to www.pfizer.com or call 1-800-438-1985.
This Instructions for Use has been approved by the U.S. Food and Drug Administration. Issued: 10/2024
Thromboembolic Events
Inform patients and/or caregivers that HYMPAVZI increases coagulation potential. Discuss the appropriate dosing of concomitant agents such as FVIII or FIX with the patient prior to starting on HYMPAVZI prophylaxis [see Warnings and Precautions (5.1)]. Advise the patient to seek immediate medical attention if any signs or symptoms of thromboembolism occur.
Hypersensitivity
Inform patients and/or caregivers that hypersensitivity reactions such as rash and pruritus are possible. Advise patients to discontinue HYMPAVZI and seek immediate emergency treatment if a severe hypersensitivity reaction occurs [see Warnings and Precautions (5.2)].
Pregnancy
Advise female patients of reproductive potential to use effective contraception during treatment with HYMPAVZI and for 2 months after the last dose. Advise patients to report known pregnancies [see Warnings and Precautions (5.3) and Use in Specific Populations (8.1, 8.3)].
This product’s labeling may have been updated. For the most recent prescribing information, please visit www.pfizer.com.
For medical information about HYMPAVZI, please visit www.pfizermedinfo.com or call 1-800-438-1985.
US License No. 2001
Distributed by
Pfizer Labs
Division of Pfizer Inc.
New York, NY 10001
LAB-1556-1.0
This Patient Information has been approved by the U.S. Food and Drug Administration. Issued: 10/2024 | ||
PATIENT INFORMATION HYMPAVZI (him-PAV-zee) (marstacimab-hncq) injection, for subcutaneous use | ||
Important information: Before you start using HYMPAVZI, it is very important to talk to your healthcare provider about using factor VIII and factor IX products (products that help blood clot but work in a different way than HYMPAVZI). You may need to use factor VIII or factor IX medicines to treat episodes of breakthrough bleeding during treatment with HYMPAVZI. Carefully follow your healthcare provider’s instructions regarding when to use factor VIII or factor IX medicines and the prescribed dose during your treatment with HYMPAVZI. | ||
What is HYMPAVZI? HYMPAVZI is a prescription medicine used to prevent or reduce the frequency of bleeding episodes in adults and children 12 years of age and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors. It is not known if HYMPAVZI is safe and effective in children younger than 12 years old. | ||
Before using HYMPAVZI, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription medicines, over‑the‑counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine. | ||
How should I use HYMPAVZI? See the detailed “Instructions for Use” that comes with your HYMPAVZI for information on how to inject a dose of HYMPAVZI, and how to properly throw away (dispose of) used HYMPAVZI prefilled syringe or HYMPAVZI prefilled pen.
| ||
What are the possible side effects of HYMPAVZI? HYMPAVZI may cause serious side effects, including:
| ||
|
| |
| ||
|
| |
The most common side effects of HYMPAVZI are injection site reactions, including: | ||
|
| |
These are not all of the possible side effects of HYMPAVZI. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. | ||
How should I store HYMPAVZI?
Keep HYMPAVZI and all medicines out of the reach of children. | ||
General information about the safe and effective use of HYMPAVZI. Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use HYMPAVZI for a condition for which it was not prescribed. Do not give HYMPAVZI to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about HYMPAVZI that is written for health professionals. | ||
What are the ingredients in HYMPAVZI? Active ingredient: marstacimab‑hncq Inactive ingredients: edetate disodium, histidine, L-histidine monohydrochloride, polysorbate 80, sucrose, and water for injection | ||
This product's labeling may have been updated. For the most recent prescribing information, please visit www.pfizer.com.
|
INSTRUCTIONS FOR USE
HYMPAVZI™ (him-PAV-zee)
(marstacimab-hncq)
injection, for subcutaneous use
single-dose prefilled syringe
This Instructions for Use contains information on how to inject HYMPAVZI.
Read this Instructions for Use carefully before using HYMPAVZI Prefilled Syringe and each time you get a refill prescription as there may be new information.
Your healthcare provider should show you or your caregiver how to prepare and inject a dose of HYMPAVZI the right way before you use it for the first time. Do not inject yourself or someone else until you have been shown how to inject HYMPAVZI.
Important Information You Need to Know Before Injecting HYMPAVZI
Storing HYMPAVZI
Supplies Needed For HYMPAVZI Injection
Gather the following supplies on a clean flat surface:
Included in the carton:
Not included in the carton:
HYMPAVZI Prefilled Syringe
Always hold HYMPAVZI Prefilled Syringe by the barrel to prevent damage.
Preparing to Inject HYMPAVZI
Step 1 – Getting Ready
Note: For a more comfortable injection, allow the Syringe to warm up to room temperature in the carton away from direct sunlight for about 15 to 30 minutes.
Do not use any other methods to warm up the Syringe, such as warming the Syringe in a microwave or hot water.
Step 2 – Check Expiration Date
Step 3 – Check Medicine
Note: It is normal to see air bubbles in the Syringe.
If you have any questions about the medicine, contact your healthcare provider.
Step 4 – Choose and Clean Your Injection Site
Step 5 – Remove Cover
Note: It is normal to see a few drops of medicine at the needle tip.
Caution: Handle the Syringe with care to avoid an accidental needle injury.
Injecting HYMPAVZI
Step 6 – Insert Needle
Keep your skin pinched throughout the injection.
Caution: If you change your mind where to inject after inserting the needle into your skin, you will need to throw away (dispose of) the Syringe and get a new HYMPAVZI Prefilled Syringe.
Step 7 – Inject Medicine
Note: Count slowly to 5 after the plunger rod has been fully pushed down before removing the needle from your skin.
Step 8 – Remove Needle
Note: If you see a small drop of medicine on your skin, wait a little longer before removing the needle when you give your next injection.
Step 9 – Check Syringe
If the gray plunger stopper is not in the position shown, this means you have not received a full dose. Call your healthcare provider for help.
Never re-insert the needle.
Do not inject another dose.
Step 10 – After Care
Note: If bleeding does not stop, contact your healthcare provider.
Note: If your prescribed dose requires 2 injections of HYMPAVZI, repeat steps 1-10. Change (rotate) the injection site each time you give yourself an injection of HYMPAVZI. You may use the same area of your body but be sure to choose a different injection site in that area.
Never re-cap the needle.
Note: If you do not have an FDA-cleared sharps disposal container, please see the “Safe Syringe Disposal” information section.
US License No. 2001
Distributed by
Pfizer Labs
Division of Pfizer Inc.
New York, NY 10001
LAB-1576-1.0
For more information, go to www.pfizer.com or call 1-800-438-1985.
This Instructions for Use has been approved by the U.S. Food and Drug Administration. Issued: 10/2024
INSTRUCTIONS FOR USE
HYMPAVZI™ (him-PAV-zee)
(marstacimab-hncq)
injection, for subcutaneous use
single-dose prefilled pen
This Instructions for Use contains information on how to inject HYMPAVZI.
Read this Instructions for Use carefully before using HYMPAVZI Prefilled Pen and each time you get a refill prescription as there may be new information.
Your healthcare provider should show you or your caregiver how to prepare and inject a dose of HYMPAVZI the right way before you use it for the first time. Do not inject yourself or someone else until you have been shown how to inject HYMPAVZI.
Important Information You Need to Know Before Injecting HYMPAVZI
Storing HYMPAVZI
Supplies Needed For HYMPAVZI Injection
Gather the following supplies on a clean flat surface:
Included in the carton:
Not included in the carton:
HYMPAVZI Prefilled Pen
Preparing to Inject HYMPAVZI
Step 1 – Getting Ready
Note: For a more comfortable injection, allow the Pen to warm up to room temperature in the carton away from direct sunlight for about 15 to 30 minutes.
Do not use any other methods to warm up the Pen, such as warming the Pen in a microwave or hot water.
Step 2 – Check Expiration Date
Step 3 – Check Medicine
Note: It is normal to see air bubbles in the window.
If you have any questions about the medicine, contact your healthcare provider.
Step 4 – Choose and Clean Your Injection Site
Step 5 – Twist Off Cap
Note:
Caution: Handle the Pen with care as it contains a needle.
Do not put or press your hand over the needle guard. Doing so may cause a needle injury.
Injecting HYMPAVZI
Step 6 – Inject Medicine
Do not remove the Pen from your skin until you have counted slowly to 5 after you hear the 2nd click and until the yellow marker completely fills the window (see “Step 7 – Remove Pen”).
Note: The needle goes into your skin as you push the Pen down. Your healthcare provider may suggest gently pinching your skin while you inject.
Note: If you do not hear a click when pushing the Pen against your skin, try pushing down harder. If you still cannot start the injection, get a new HYMPAVZI Prefilled Pen.
Caution: If you change your mind where to inject after inserting the needle into your skin, you will need to throw away (dispose of) the Pen and get a new HYMPAVZI Prefilled Pen.
Note: After you remove the Pen from your skin, the needle guard will automatically cover the needle and lock in place.
The Pen cannot be reused.
Step 8 – Check Window
If the yellow bar is not in the position shown, this means you have not received a full dose. Call your healthcare provider for help.
Do not inject another dose.
Step 9 – After Care
Note: If bleeding does not stop, contact your healthcare provider.
Note: If your prescribed dose requires 2 injections of HYMPAVZI, repeat steps 1-9. Change (rotate) the injection site each time you give yourself an injection of HYMPAVZI. You may use the same area of your body but be sure to choose a different injection site in that area.
Note: If you do not have an FDA-cleared sharps disposal container, please see the “Safe Pen Disposal” information section.
US License No. 2001
Distributed by
Pfizer Labs
Division of Pfizer Inc.
New York, NY 10001
LAB-1577-1.0
For more information, go to www.pfizer.com or call 1-800-438-1985.
This Instructions for Use has been approved by the U.S. Food and Drug Administration. Issued: 10/2024
Thromboembolic Events
Inform patients and/or caregivers that HYMPAVZI increases coagulation potential. Discuss the appropriate dosing of concomitant agents such as FVIII or FIX with the patient prior to starting on HYMPAVZI prophylaxis [see Warnings and Precautions (5.1)]. Advise the patient to seek immediate medical attention if any signs or symptoms of thromboembolism occur.
Hypersensitivity
Inform patients and/or caregivers that hypersensitivity reactions such as rash and pruritus are possible. Advise patients to discontinue HYMPAVZI and seek immediate emergency treatment if a severe hypersensitivity reaction occurs [see Warnings and Precautions (5.2)].
Pregnancy
Advise female patients of reproductive potential to use effective contraception during treatment with HYMPAVZI and for 2 months after the last dose. Advise patients to report known pregnancies [see Warnings and Precautions (5.3) and Use in Specific Populations (8.1, 8.3)].
This product’s labeling may have been updated. For the most recent prescribing information, please visit www.pfizer.com.
For medical information about HYMPAVZI, please visit www.pfizermedinfo.com or call 1-800-438-1985.
US License No. 2001
Distributed by
Pfizer Labs
Division of Pfizer Inc.
New York, NY 10001
LAB-1556-1.0
This Patient Information has been approved by the U.S. Food and Drug Administration. Issued: 10/2024 | ||
PATIENT INFORMATION HYMPAVZI (him-PAV-zee) (marstacimab-hncq) injection, for subcutaneous use | ||
Important information: Before you start using HYMPAVZI, it is very important to talk to your healthcare provider about using factor VIII and factor IX products (products that help blood clot but work in a different way than HYMPAVZI). You may need to use factor VIII or factor IX medicines to treat episodes of breakthrough bleeding during treatment with HYMPAVZI. Carefully follow your healthcare provider’s instructions regarding when to use factor VIII or factor IX medicines and the prescribed dose during your treatment with HYMPAVZI. | ||
What is HYMPAVZI? HYMPAVZI is a prescription medicine used to prevent or reduce the frequency of bleeding episodes in adults and children 12 years of age and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors. It is not known if HYMPAVZI is safe and effective in children younger than 12 years old. | ||
Before using HYMPAVZI, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription medicines, over‑the‑counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine. | ||
How should I use HYMPAVZI? See the detailed “Instructions for Use” that comes with your HYMPAVZI for information on how to inject a dose of HYMPAVZI, and how to properly throw away (dispose of) used HYMPAVZI prefilled syringe or HYMPAVZI prefilled pen.
| ||
What are the possible side effects of HYMPAVZI? HYMPAVZI may cause serious side effects, including:
| ||
|
| |
| ||
|
| |
The most common side effects of HYMPAVZI are injection site reactions, including: | ||
|
| |
These are not all of the possible side effects of HYMPAVZI. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. | ||
How should I store HYMPAVZI?
Keep HYMPAVZI and all medicines out of the reach of children. | ||
General information about the safe and effective use of HYMPAVZI. Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use HYMPAVZI for a condition for which it was not prescribed. Do not give HYMPAVZI to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about HYMPAVZI that is written for health professionals. | ||
What are the ingredients in HYMPAVZI? Active ingredient: marstacimab‑hncq Inactive ingredients: edetate disodium, histidine, L-histidine monohydrochloride, polysorbate 80, sucrose, and water for injection | ||
This product's labeling may have been updated. For the most recent prescribing information, please visit www.pfizer.com.
|
INSTRUCTIONS FOR USE
HYMPAVZI™ (him-PAV-zee)
(marstacimab-hncq)
injection, for subcutaneous use
single-dose prefilled syringe
This Instructions for Use contains information on how to inject HYMPAVZI.
Read this Instructions for Use carefully before using HYMPAVZI Prefilled Syringe and each time you get a refill prescription as there may be new information.
Your healthcare provider should show you or your caregiver how to prepare and inject a dose of HYMPAVZI the right way before you use it for the first time. Do not inject yourself or someone else until you have been shown how to inject HYMPAVZI.
Important Information You Need to Know Before Injecting HYMPAVZI
Storing HYMPAVZI
Supplies Needed For HYMPAVZI Injection
Gather the following supplies on a clean flat surface:
Included in the carton:
Not included in the carton:
HYMPAVZI Prefilled Syringe
Always hold HYMPAVZI Prefilled Syringe by the barrel to prevent damage.
Preparing to Inject HYMPAVZI
Step 1 – Getting Ready
Note: For a more comfortable injection, allow the Syringe to warm up to room temperature in the carton away from direct sunlight for about 15 to 30 minutes.
Do not use any other methods to warm up the Syringe, such as warming the Syringe in a microwave or hot water.
Step 2 – Check Expiration Date
Step 3 – Check Medicine
Note: It is normal to see air bubbles in the Syringe.
If you have any questions about the medicine, contact your healthcare provider.
Step 4 – Choose and Clean Your Injection Site
Step 5 – Remove Cover
Note: It is normal to see a few drops of medicine at the needle tip.
Caution: Handle the Syringe with care to avoid an accidental needle injury.
Injecting HYMPAVZI
Step 6 – Insert Needle
Keep your skin pinched throughout the injection.
Caution: If you change your mind where to inject after inserting the needle into your skin, you will need to throw away (dispose of) the Syringe and get a new HYMPAVZI Prefilled Syringe.
Step 7 – Inject Medicine
Note: Count slowly to 5 after the plunger rod has been fully pushed down before removing the needle from your skin.
Step 8 – Remove Needle
Note: If you see a small drop of medicine on your skin, wait a little longer before removing the needle when you give your next injection.
Step 9 – Check Syringe
If the gray plunger stopper is not in the position shown, this means you have not received a full dose. Call your healthcare provider for help.
Never re-insert the needle.
Do not inject another dose.
Step 10 – After Care
Note: If bleeding does not stop, contact your healthcare provider.
Note: If your prescribed dose requires 2 injections of HYMPAVZI, repeat steps 1-10. Change (rotate) the injection site each time you give yourself an injection of HYMPAVZI. You may use the same area of your body but be sure to choose a different injection site in that area.
Never re-cap the needle.
Note: If you do not have an FDA-cleared sharps disposal container, please see the “Safe Syringe Disposal” information section.
US License No. 2001
Distributed by
Pfizer Labs
Division of Pfizer Inc.
New York, NY 10001
LAB-1576-1.0
For more information, go to www.pfizer.com or call 1-800-438-1985.
This Instructions for Use has been approved by the U.S. Food and Drug Administration. Issued: 10/2024
INSTRUCTIONS FOR USE
HYMPAVZI™ (him-PAV-zee)
(marstacimab-hncq)
injection, for subcutaneous use
single-dose prefilled pen
This Instructions for Use contains information on how to inject HYMPAVZI.
Read this Instructions for Use carefully before using HYMPAVZI Prefilled Pen and each time you get a refill prescription as there may be new information.
Your healthcare provider should show you or your caregiver how to prepare and inject a dose of HYMPAVZI the right way before you use it for the first time. Do not inject yourself or someone else until you have been shown how to inject HYMPAVZI.
Important Information You Need to Know Before Injecting HYMPAVZI
Storing HYMPAVZI
Supplies Needed For HYMPAVZI Injection
Gather the following supplies on a clean flat surface:
Included in the carton:
Not included in the carton:
HYMPAVZI Prefilled Pen
Preparing to Inject HYMPAVZI
Step 1 – Getting Ready
Note: For a more comfortable injection, allow the Pen to warm up to room temperature in the carton away from direct sunlight for about 15 to 30 minutes.
Do not use any other methods to warm up the Pen, such as warming the Pen in a microwave or hot water.
Step 2 – Check Expiration Date
Step 3 – Check Medicine
Note: It is normal to see air bubbles in the window.
If you have any questions about the medicine, contact your healthcare provider.
Step 4 – Choose and Clean Your Injection Site
Step 5 – Twist Off Cap
Note:
Caution: Handle the Pen with care as it contains a needle.
Do not put or press your hand over the needle guard. Doing so may cause a needle injury.
Injecting HYMPAVZI
Step 6 – Inject Medicine
Do not remove the Pen from your skin until you have counted slowly to 5 after you hear the 2nd click and until the yellow marker completely fills the window (see “Step 7 – Remove Pen”).
Note: The needle goes into your skin as you push the Pen down. Your healthcare provider may suggest gently pinching your skin while you inject.
Note: If you do not hear a click when pushing the Pen against your skin, try pushing down harder. If you still cannot start the injection, get a new HYMPAVZI Prefilled Pen.
Caution: If you change your mind where to inject after inserting the needle into your skin, you will need to throw away (dispose of) the Pen and get a new HYMPAVZI Prefilled Pen.
Note: After you remove the Pen from your skin, the needle guard will automatically cover the needle and lock in place.
The Pen cannot be reused.
Step 8 – Check Window
If the yellow bar is not in the position shown, this means you have not received a full dose. Call your healthcare provider for help.
Do not inject another dose.
Step 9 – After Care
Note: If bleeding does not stop, contact your healthcare provider.
Note: If your prescribed dose requires 2 injections of HYMPAVZI, repeat steps 1-9. Change (rotate) the injection site each time you give yourself an injection of HYMPAVZI. You may use the same area of your body but be sure to choose a different injection site in that area.
Note: If you do not have an FDA-cleared sharps disposal container, please see the “Safe Pen Disposal” information section.
US License No. 2001
Distributed by
Pfizer Labs
Division of Pfizer Inc.
New York, NY 10001
LAB-1577-1.0
For more information, go to www.pfizer.com or call 1-800-438-1985.
This Instructions for Use has been approved by the U.S. Food and Drug Administration. Issued: 10/2024
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.